News Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Real-time Estimate Cboe BZX Other stock markets 01:25:50 01/05/2024 am IST			5-day change	1st Jan Change
3.065 ^USD	-8.23%		-4.84%	-5.43%

01:31pm	B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	MT
29/04	HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

B. Riley Securities Initiates Ovid Therapeutics With Buy Rating, $9 Price Target	05:01pm	MT
HC Wainwright Starts Ovid Therapeutics With Buy Rating, $9 Price Target	29/04	MT
Ovid Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference	04/04	GL
Marinus Pharmaceuticals Comments on Patent Challenge by Ovid Therapeutics Inc. and Provides Update on Marinus Post Grant Review	28/03	AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	08/03	CI
Ovid Therapeutics : Corporate Presentation	08/03	PU
Earnings Flash (OVID) OVID THERAPEUTICS Reports Q4 Revenue $141,562	08/03	MT
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08/03	GL
Ovid Therapeutics Reports Business Updates, Fourth Quarter and Full Year 2023 Financial Results	08/03	AQ
Ovid Therapeutics Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	08/03	CI
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02	GL
Ovid Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference	28/02	AQ
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	GL
Ovid Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference	06/02	AQ
BTIG Initiates Ovid Therapeutics With Buy Rating, Price Target is $11	21/12	MT
Ovid Therapeutics Inc.(NasdaqGS:OVID) added to NASDAQ Biotechnology Index	18/12	CI
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting	04/12	AQ
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01/12	GL
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)	01/12	AQ
Ovid Therapeutics : Corporate Presentation	03/11	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ovid Therapeutics Inc.

Equities

OVID

US6904691010

Summary

Filters